The heart and the mountains;Cœur et montagne

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 11, 2006, Pages 1121-1125

  Brion, R ^a  

^a HIA Desgenettes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ALTITUDE; CALCULATION; CARDIOLOGIST; CARDIOVASCULAR RISK; CLINICAL EVALUATION; ENVIRONMENTAL EXPOSURE; FUNCTIONAL STATUS; HEART DISEASE; HUMAN; HYPERTENSION; HYPOXIA; ISCHEMIC HEART DISEASE; MOUNTAINEERING; PHYSICAL ACTIVITY; PULMONARY HYPERTENSION; REVIEW; TASK PERFORMANCE; THROMBOEMBOLISM; ADAPTATION; ANOXIA; CARDIOVASCULAR DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADAPTATION, PHYSIOLOGICAL; ANOXIA; CARDIOVASCULAR DISEASES; HUMANS; MOUNTAINEERING; RISK FACTORS;

EID: 33846859312     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Ponchia A, Biasin R. Cardiovascular risk during physical activity in the mountains. J Cardiovasc Med (Hagerstown) 2006;7:129-35.
2. Richalet JP. Adaptation cardiovasculaire à l'altitude. AMC Pratique 2005;143:15-18S.
3. Savourey G, Launay JC. Le mal aigu des montagnes. AMC Pratique 2005;143:19-21.
4. Allemann Y, Rotter M. Impact of acute hypoxic pulmonary hypertension on LV diastolic function in healthy mountaineers at high altitude. Am J Physiol Heart Circ Physiol 2004;286(3):H856-62.
5. Domej W, Schwaberger G. Respiratory adaptation to altitude and risk factors due to respiratory illnesses. Wien Med Wochenschr 2000;150:163-8.
6. Groves BM, Reeves JT. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 1987;63:521-30.
7. Villafuerte FC, Cardenas R, Monge C. Optimal hemoglobin concentration and high altitude: a theoretical approach for Andean men at rest. J Appl Physiol 2004;96:1581-8.
8. Cucinell SA, Pitts CM. Thrombosis at mountain altitudes. Aviat Space Environ Med 1987;58:1109-11.
9. Kashyap AS, Anand KP, et al. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;353:314-5.
10. Bernheim A. High altitude and cardiac disease. Schweiz Rundsch Med Prax 2005;94:1760-4.
11. Abinader EG, Sharif D, et al. Effects of low altitude on exercise performance in patients with congestive heart failure after healing of acute myocardial infarction. Am J Cardiol 1999;83:383-7.
12. Wyss CA, Koepfli P, et al. Influence of altitude exposure on coronary flow reserve. Circulation 2003:108:1202-7.
13. Abinader EG, Sharif D, et al. Effect of low altitude (Dead Sea location) on exercise performance and wall motion in patients with coronary artery disease. Am J Cardiol 1999;83:250-1, A5.
14. Schmid JP, Noveanu M, et al. Safety and exercise tolerance of acute high altitude exposure (3 454 m) among patients with coronary artery disease. Heart 2006;92:921-5.
15. Horii M, Takasaki I, et al. Changes of heart rate and QT interval at high altitude in alpinists: analysis by Holter ambulatory electrocardiogram. Clin Cardiol 1987;10:238-42.
16. Fuenmayor AJ, Stock FU, et al. QT interval and final portion of T wave: measurements and dispersion in infants born at high altitude. Int J Cardiol 2002;82:123-6.
17. Faulhaber M, Flatz M, et al. Beta-blockers may provoke oxygen desaturation during submaximal exercise at moderate altitudes in elderly persons. High Alt Med Biol 2003;4:475-8.
18. Agostoni P, Contini M, et al. Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. Eur J Heart Fail 2006;10.